Trials / Completed
CompletedNCT03340818
Bone Marrow Concentrate Intradiscal Injection for Chronic Discogenic Low Back Pain
Bone Marrow Concentrate Intradiscal Injection for Chronic Discogenic Low Back Pain: A Double-Blind, Placebo Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 66 (actual)
- Sponsor
- APM Spine and Sports Physicians · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
A double-blind, placebo-controlled study to determine the efficacy of intradiscal injection of bone marrow concentrate on discogenic low back pain.
Detailed description
A randomized, double-blind, placebo-controlled study to determine the efficacy of intradiscal injection of bone marrow concentrate on discogenic low back pain. The treatment will be a single injection of autologous bone marrow concentrate into suspected painful disc(s) based upon either prior discography or combination of imaging and exclusion of other anatomic structural sources of pain. The placebo treatment will be an intramuscular injection of normal saline directly dorsal to the transverse process at each suspected level. Outcomes will be measured using VAS and ODI. The primary outcome will be the percentage of patients in the treatment group vs control group at 6 months post-procedure, categorized as a clinical success defined by at least 50% relief of pain. Secondary outcomes will be comparison of success rates at 3 and 12 months, percentage of patients in the two groups with greater than 30% improvement in ODI at 3, 6 and 12 months, Global perceived index at 3, 6, 12 months. Medication log and adjunctive treatments will be recorded and analyzed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Bone Marrow Concentrate | Bone marrow concentrate is bone marrow harvested from the iliac crest and minimally processed in a centrifuge. It is then injected into the suspected painful disc (s) using fluoroscopic guidance |
| OTHER | Placebo | Injection of normal saline dorsal to the transverse process after sham bone marrow aspiration |
Timeline
- Start date
- 2018-08-01
- Primary completion
- 2024-08-07
- Completion
- 2024-08-07
- First posted
- 2017-11-14
- Last updated
- 2024-08-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03340818. Inclusion in this directory is not an endorsement.